Interaction between timing of perinatal human immunodeficiency virus infection and the design of preventive and therapeutic interventions

Acta Paediatrica, International Journal of Paediatrics, Supplement

Volumn 86, Issue 421, 1997, Pages 1-9

  Mofenson, L M ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RETINOL; ZIDOVUDINE;

ACTIVE IMMUNIZATION; BREAST MILK; DIET SUPPLEMENTATION; DISEASE COURSE; DISEASE TRANSMISSION; GENETIC SUSCEPTIBILITY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; PASSIVE IMMUNIZATION; PATHOGENESIS; PERINATAL MORBIDITY; PLACENTA; PREGNANCY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; VERTICAL TRANSMISSION;

EID: 0030737731     PISSN: 08035326     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (86)

1. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med 1994; 331: 1173-80
2. Kinloch-de Loes S, Hirschel BJ, Hoen B, et al. A controlled trial of zidovudine in primary human immunodeficiency virus infection. N Engl J Med 1995; 333: 408-13
3. Sperduto AR, Bryson YJ, Chen ISY. Increased susceptibility of neonatal monocyte/macrophages to HIV-1 infection. AIDS Res Hum Retrovir 1993; 9: 1277-85
4. Ho W-Z, Lioy J, Song L, Cutilli JR, Polin RA, Douglas SD. Infection of cord blood monocyte-derived macrophages with human immunodeficiency virus type 1. J Virol 1992; 66: 573-9
5. Hays EF, Uittenbogaart CH, Brewer JC, et al. In vitro studies of HIV-1 expression in thymocytes from infants and children. AIDS 1992; 6: 265-72
6. Rosenzweig M, Clark DP, Gaulton GN. Selective thymocyte depletion in neonatal HIV-1 thymic infection. AIDS 1993; 7: 1601-5
7. Siegrist C-A, Wyler C-A, Gerritsen EAJ, Perrin L, Speiser D, Suter S. Specific tolerance to HIV-1 antigens in an infant with rapid progression to AIDS. AIDS 1993; 7: 1683-4
8. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995; 373: 123-6
9. Langsten C, Lewis DE, Hammill HA, et al. Excess intrauterine fetal demise associated with maternal human immunodeficiency virus infection. J Infect Dis 1995; 172: 1451-60
10. Minkoff H, Mofenson LM. The role of obstetric interventions in the prevention of pediatric human immunodeficiency virus. Am J Obstet Gynecol 1994; 171: 1167-75
11. Mofenson LM. Epidemiology and determinants of vertical HIV transmission. Semin Pediatr Infect Dis 1994; 5: 252-65
12. Abrams EJ, Matheson PB, Thomas PA, et al. Neonatal predictors of infection status and early death among 332 infants at risk of HIV-1 infection monitored prospectively from birth. Pediatrics 1995; 96: 451-8
13. Galli L, de Martino M, Tovo P-A, et al. Onset of clinical signs in children with HIV-1 perinatal infection. AIDS 1995; 9: 455-61
14. Dickover RE, Dillon M, Gillette SG, et al. Rapid increases in load of human immunodeficiency virus correlate with early disease progression and loss of CD4 cells in vertically infected infants. J Infect Dis 1994; 170: 1279-84
15. Blanche S, Tardieu M, Duliege A-M, et al. Longitudinal study of 94 symptomatic infants with perinatally acquired human immunodeficiency infection: evidence for a bimodal expression of clinical and biologic symptoms. Am J Dis Child 1990; 144: 1210-5
16. MaWhinney S, Pagano M, Thomas P. Age at AIDS diagnosis for children with perinatally acquired HIV. J Acq Immune Defic Syndr 1993; 6: 1139-44
17. European Collaborative Study. Children born to women with HIV-1 infection: natural history and risk of transmission. Lancet 1991; 337: 253-60
18. Duliege A-M, Amos CI, Felton S, Biggar RJ, the International Registry of HIV-Exposed Twins, Goedert JJ. Birth order, delivery route, and concordance in the transmission of human immuno-deficiency virus type 1 from mothers to twins. J Pediatr 1995; 126: 625-32
19. De Rossi A, Ometto L, Mammano F, et al. Time course of antigenemia and seroconversion in infants with vertically acquired HIV-1 infection. AIDS 1993; 7: 1528-9
20. Landesman S, Weiblen B, Mendez H, et al. Clinical utility of HIV-IgA immunoblot assay in the early diagnosis of perinatal HIV infection. J Am Med Assoc 1991; 266: 3443-6
21. Quinn TC, Kline RL, Halsey N, et al. Early diagnosis of perinatal HIV infection by detection of viral-specific IgA antibodies. J Am Med Assoc 1991; 266: 3439-42
22. Parekh BS, Shaffer N, Coughlin R, et al. Human immunodeficiency virus 1-specific IgA capture enzyme immunoassay for early diagnosis of human immunodeficiency virus type I infection in infants. Pediatr Infect Dis J 1993; 12: 908-13
23. McIntosh K, Pitt J, Brambilla D, et al. Blood culture in the first 6 months of life for the diagnosis of vertically transmitted human immunodeficiency virus infection. J Infect Dis 1994; 170: 996-1000
24. Quinn TC, Lkine R, Moss MW, Livingston RA, Hutton N. Acid dissociation of immune complexes improves diagnostic utility of p24 antigen detection in perinatally acquired human immunodeficiency virus infection. J Infect Dis 1993; 167: 1193-6
25. Burgard M, Mayaux M-J, Blanche S, et al. The use of viral culture and p24 antigen testing to diagnose human immunodeficiency virus infection in neonates. N Engl J Med 1992; 327: 1192-7
26. Kirvine A, Firtion G, Cao L, et al. HIV replication during the first few weeks of life. Lancet 1992; 339: 1187-9
27. Denamur E, Levine M, Simon F, et al. Conversion of HIV-1 viral markers during the first few months of life in HIV-infected children born to seropositive women. AIDS 1992; 7: 897-9
28. Luzuriaga K, McQuilken P, Alimenti A, et al. Early viremia and immune responses in vertical human immunodeficiency virus type 1 infection. J Infect Dis 1993; 167: 1008-13
29. Semba RD, Miotti PG, Chiphangwi JD, et al. Maternal vitamin A deficiency and mother-to-child transmission of HIV-1. Lancet 1994; 343: 1593-7
30. Semba RD. Vitamin A, immunity and infection. Clin Infect Dis 1994; 19:489-99
31. Devash Y, Calvelli TA, Wood DG, Reagan KJ, Rubinstein A. Vertical transmission of human immunodeficiency virus is correlated with the absence of high-affinity/avidity maternal antibodies to the gp120 principal neutralizing domain. Proc Natl Acad Sci USA 1990; 87: 3445-9
32. Robertson CA, Mok JYQ, Froebel KS, et al. Maternal antibodies to gp120 sequence do not correlate with protection against vertical transmission of human immunodeficiency virus. J Infect Dis 1992; 166: 704-9
33. Geffin RB, Lai S, Hutto C, et al. Quantitative analysis of human immunodeficiency virus type 1 antibody reactivity by western immunoblots: evalution of relative antibody levels in seropositive individuals and mothers. J Infect Dis 1992; 165: 111-8
34. Parekh BS, Shaffer N, Pau C-P, et al. Lack of correlation between maternal antibodies to V3 loop peptides of gp120 and perinatal HIV-1 transmission. AIDS 1991; 5: 1179-84
35. Khoruri YF, McIntosh K, Cavacini L, et al. Vertical transmission of HIV-1 : correlation with maternal viral load and plasma levels of CD4 binding site anti-gp120 antibodies. J Clin Invest 1995; 95: 732-7
36. St. Louis ME, Pau DP, Nsuami M, et al. Lack of association between anti-V3 loop antibody and perinatal HIV-1 transmission in Kinshasa, Zaire, despite use of assays based on local HIV-1 strains. J Acq Immune Defic Syndr 1994; 7: 63-7
37. Erb P, Krauchi S, Burgin D, et al. Quantitative anti-p24 determinations can predict the risk of vertical transmission. J Acq Immune Defic Syndr 1994; 7: 261-4
38. Jackson JB, Kataaha P, Horn DL, et al. β-2 microglobulin, HIV-1 p24 antibody and acid-dissociated HIV-1 p24 antigen levels: predictive markers for vertical transmission of HIV-1 in pregnant Ugandan women. AIDS 1993; 7: 1475-9
39. Epstein H, Guay L, Horn D, et al. Lack of association between anti-V3 loop antibodies and perinatal transmission of HIV-1 in Kampala, Uganda. Pediatr AIDS HIV Infect Fetus Adolesc 1994; 5: 350-6
40. Lallemant M, Baillou A, Lallemant-le Coeur, et al. Maternal antibody response at delivery and perinatal transmission of human immunodeficiency virus type 1 in African women. Lancet 1994; 343: 1001-5
41. Goedert JJ, Dublin S for the Mothers and Infants Cohort Study and the HIV-1 Perinatal Serology Working Group. Perinatal transmission of HIV type 1: associations with maternal anti-HIV serological reactivity. AIDS Res Hum Retrovir 1994; 10: 1125-34
42. Markham RB, Coberly J, Ruff AJ, et al. Maternal IgG1 and IgA antibody to V3 loop consensus sequence and maternal-infant HIV-1 transmission. Lancet 1994; 343: 390-1
43. Scarlatti G, Albert J, Rossi P, et al. Mother-to-child transmission of human immunodeficiency virus type I: correlation with neutralizing antibodies against primary isolates. J Infect Dis 1993; 168: 207-10
44. Kliks SC, Wara DW, Landers DV, Levy JA. Features of HIV-1 that could influence maternal-child transmission. J Am Med Assoc 1994; 272: 467-74
45. Husson RN, Lan Y, Kojima E, Venzon D, Mitsuya H, McIntosh K. Vertical transmission of human immunodeficiency virus type 1: autologous neutralizing antibody, virus load, and virus phenotype. J Pediatr 1995; 126:865-71
46. Ljunggren K, Moschese V, Borliden P-A, et al. Antibodies mediating cellular cytotoxicity and neutralization correlate with better clinical stage in children born to human immunodeficiency virus-infected mothers. J Infect Dis 1990; 161: 198-202
47. Borkowsky W, Krasinski K, Cao Y, et al. Correlation of perinatal transmission of human immunodeficiency virus type 1 with maternal viremia and lymphocyte phenotypes. J Pediatr 1994; 125: 345-51
48. Weiser B, Nachman S, Tropper P, et al. Quantitation of human immunodeficiency virus type 1 during pregnancy: relationship of viral tiler to mother-to-child transmission and stability of viral load. Proc Natl Acad Sci USA 1994; 91: 8031-41
49. Dickover RE, Garratty EM, Horman SA, et al. Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission: effect of maternal zidovudine treatment on viral load. J Am Med Assoc 1996; 275: 599-605
50. Sperling RS, Shapiro DE, Coombs R, et al. Maternal plasma HIV-1 RNA and the success of zidovudine (ZDV) in the prevention of mother-child transmission. Abstracts of the Third National Conference on Retroviruses and Opportunistic Infections, 28 January-1 February 1996, Washington, DC. Abstract LB1
51. Koup RA, Cao Y, Ho DD, et al. Lack of a maternal viral threshold for vertical transmission of HIV-1. Abstracts of the Third National Conference on Retroviruses and Opportunistic Infections, 28 January- 1 February 1996, Washington, DC. Abstract LB2
52. Burchett SK, Kornegay J, Pitt J, et al. Assessment of maternal plasma HIV viral load as a correlate of vertical transmission. Abstracts of the Third National Conference on Retroviruses and Opportunistic Infections, 28 January-1 February 1996, Washington, DC. Abstract LB3
53. Ometto L, Zanotto C, Maccabruni A, et al. Viral phenotype and host-cell susceptibility to HIV-1 infection as risk factors for mother-to-child HIV-1 transmission. AIDS 1995; 9: 427-34
54. Wolinsky SM, Wike CM, Korber BTM, et al. Selective transmission of human immunodeficiency virus type 1 variant from mothers to infants. Science 1992; 255: 1134-7
55. Ahmad N, Baroudy BM, Baker RC, CHappey C. Genetic analysis of human immunodeficiency virus type 1 envelope V3 region isolates from mothers and infants after perinatal transmission. J Virol 1995; 69: 1001-12
56. Douglas GC, King BF. Maternal-fetal transmission of human immunodeficiency virus: a review of possible routes and cellular mechanisms of infection. Clin Infect Dis 1992; 15: 678-91
57. Toth FD, Mosborg-Petersen P, Kiss J, et al. Antibody-dependent enhancement of HIV-1 infection in human term syncytiotrophoblast cells cultured in vitro. Clin Exp Immunol 1994; 96: 389-94
58. + levels. J Acquir Immune Defic Syndr 1994; 7: 718-26
59. Rodriguez EM, Mofenson LM, Chang B-H, et al. Association of maternal drug use during pregnancy with maternal HIV culture positively and perinatal HIV transmission in the Women and Infants Transmission Study. AIDS 1996, in press
60. St. Louis ME, Kamenga M, Brown C, et al. Risk for perinatal HIV-1 transmission according to maternal immunologic, virologic and placental factors. J Am Med Assoc 1993; 269: 2853-9
61. Just JJ, Abrams E, Louie LG, et al. Influence of host genotype on progression to acquired immunodeficiency syndrome among children infected with human immunodeficiency virus type 1. Pediatrics 1995; 127: 544-9
62. Clemetson DB, Moss GB, Willerford DM, et al. Detection of HIV DNA in cervical and vaginal secretions: prevalence and correlates among women in Nairobi, Kenya. J Am Med Assoc 1993; 269: 2860-4
63. Henin Y, Mandelbrot L, Henrion R, et al. Virus excretion in the cervicovaginal secretions of pregnant and nonpregnant HIV-infected women. J Acq Immune Defic Syndr 1993; 6: 72-5
64. Giannetti A, Zambruno G, Cimarelli A, et al. Direct detection of HIV-1 RNA in epidermal Langerhans cells of HIV-infected patients. J Acq Immune Defic Syndr 1993; 6: 229-33
65. Fleming SC, Kapembwa MS, MacDonald TT, et al. Direct in vitro infection of human intestine with HIV-1. AIDS 1992; 6: 1099-104
66. Fazely F, Sharma PL, Fratazzi C, et al. Simian immunodeficiency virus infection via amniotic fluid: a model to study fetal immunopathogenesis and prophylaxis. J Acq Immune Defic Syndr 1993; 6: 107-14
67. Baba TW, Koch J, Mittler ES, et al. Mucosal infection of neonatal rhesus monkeys with cell-free SIV. AIDS Res Hum Retrovir 1994; 10:351-7
68. Whaley KJ, Zeitlin L, Barrait RA, Hoen TE, Cone RA. Passive immunization of the vagina protects mice against vaginal transmission of genital herpes infections. J Infect Dis 1994; 169: 647-9
69. Miotti P, Yolken R, Canner J, et al. Mucosal factors and transmission of HIV from mother to infant. Proceedings of the First National Conference on Human and Other Relaled Retroviruses, 12-16 December 1993, Washington, DC. Abstract 673
70. Minkoff H, Bums DN, Landesman S, et al. The relationship of the duration of ruptured membranes to vertical transmission of human immunodeficiency virus. Am J Obstet Gynecol 1995; 173: 585-9
71. Landesman SH, Burns D, Kalish L, et al. Increased duration of ruplure of membranes is associated with increased risk of perinatal HIV-1 transmission. Presented at the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy, 4-7 October 1994, Orlando, FI. Abstract I19
72. Mofenson LM. A critical review of studies evaluating the relationship of mode of delivery to perinatal transmission of human immunodeficiency virus. Pediatr Infect Dis J 1995; 14: 169-77
73. Biggar RJ, Miotti P, Taha T, Waters D, Mtimivalye L. Perinatal HIV-1 transmission in Africa and the effect of birth canal cleaning. Abstracts of the Third National Conference on Retroviruses and Opportunistic Infections, 28 January-1 February 1995, Washington, DC. Abstract 27
74. Bakski SS, Tetali S, Abrams EJ, Paul MO, Pahwa SG. Repeatedly positive human immunodeficiency virus type 1 DNA polymerase chain reaction in human immunodeficiency virus-exposed seroreverting infants. Pediatr Infect Dis J 1995; 14: 658-62
75. Bryson YJ, Pang S, Wei LS, Dickover R, Diagne A, Chen ISY. Clearance of HIV infection in a perinatally infected infant. N Engl J Med 1995;332:833-8
76. Newell M-L, Dunn D, De Maria A, et al. Detection of virus in vertically exposed HIV-antibody negative children
77. Clerici M, Sison AV, Berzofsky JA, et al. Cellular immune factors associated with mother-to-infant transmission of HIV. AIDS 1993; 7: 1427-33
78. Rowland-Jones SL, Nixon DF, Aldhous MC, et al. HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infant. Lancet 1993; 341: 860-1
79. De Maria A, Cirillo C, Moretta L. Occurrence of human immunodeficiency virus type l (HIV-l)-specific cytolytic T cell activity in apparently uninfected children born to HIV-1-infected mothers. J Infect Dis 1994; 170: 1296-9
80. Froebel KS, Aldhous MC, Mok JYQ, Hayley J, Arnott M, Peutherer JF. Cytotoxic T lymphocyte activity in children infected with HIV. AIDS Res Hum Retrovir 1994; 10 Supp 2: S83-8
81. Newburg DS, Linhardt R, Ampofo SA, Yolken RH. Human milk glycosaminoglycans inhibit HIV glycoprotein gp120 binding to its host cell CD4 receptor. J Nutr 1995; 125: 419-24
82. Van de Perre P, Simonon A, Hitimana D-G, et al. Infective and antiinfective properties of breastmilk from HIV-1-infected women. Lancet 1993:341:914-8
83. Datta P, Embree JE, Kreiss JK. Resumption of breast-feeding in later childhood: a risk factor for mother to child human immunodeficiency virus type 1 transmission. Pediatr Infect Dis J 1992; 11: 974-6
84. Nicoll A, Newell M-L, Van Pragg E, Van de Perre P, Peckham C. Infant feeding policy and practice in the presence of HIV-1 infection. AIDS 1995; 9: 107-19
85. Van Rompay KKA, Otsyula MG, Marthas ML, Miller CJ, McChesney MB, Pedersen NC. Immediate zidovudine treatment protects simian immunodeficiency virus-infected newborn macaques against rapid onset of AIDS. Antimicrob Agents Chemother 1995; 39: 125-31
86. Rausch DM, Heyes MP, Murray EA, Eiden LE. Zidovudine treatment prolongs survival and decreases viral load in the central nervous system of rhesus macaques infected perinatally with simian immunodeficiency virus. J Infect Dis 1995; 172: 59-69